Evaluation of extended thymectomy approaches based on residual fat tissue.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
22 01 2021
Historique:
received: 08 05 2020
revised: 01 09 2020
accepted: 20 09 2020
pubmed: 26 11 2020
medline: 22 7 2021
entrez: 25 11 2020
Statut: ppublish

Résumé

This study analysed the patterns of extraction ranges, characteristics, advantages and disadvantages of median sternotomy (MS) and subxiphoid (SX) approaches for extended thymectomy. This study included patients with anterior mediastinum tumour and myasthenia gravis who underwent extended thymectomy at our institution between 2015 and 2018. There were 5 MS and 6 SX extended thymectomy surgeries with the VINCENT software. On preoperative computed tomography, the thymus area and fat tissue surrounding the thymus, which were planned for extraction, were traced using VINCENT (Ver. 4.0). We then constructed three-dimensional images and calculated the volumes. Evaluation of the extended thymectomy approach based on the residual fat tissue was required to determine the area of extended thymectomy. No significant differences in operation time (min) [SX: 197.3 ± 34.0, MS: 206.6 ± 91.4, drainage duration (days), SX: 2.2 ± 1.0, MS: 2.2 ± 0.4, hospital stay (days), SX: 11.8 ± 1.2, MS: 13.4 ± 2.1, residual rate (%), SX: 29.9 ± 17.5, MS: 58.7 ± 18.0 (P = 0.0519)] were observed between the 2 groups. Bleeding was significantly lower for SX than for MS. The residual rate was lower for SX than for MS. Considering the amount of the residual fat tissue, the SX approach allows an adequate dissection area for extended thymectomy compared with the MS approach.

Identifiants

pubmed: 33236060
pii: 6000415
doi: 10.1093/icvts/ivaa242
pmc: PMC8906765
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

250-255

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

J Gastrointest Surg. 2010 Sep;14(9):1473
pubmed: 20596787
J Thorac Cardiovasc Surg. 2012 Mar;143(3):601-6
pubmed: 22177829
Asian Cardiovasc Thorac Ann. 2003 Dec;11(4):323-7
pubmed: 14681093
Surg Endosc. 2011 Feb;25(2):408-15
pubmed: 20602141
Gen Thorac Cardiovasc Surg. 2014 Sep;62(9):570-2
pubmed: 24170660
Ann Thorac Surg. 2004 Jul;78(1):253-8
pubmed: 15223438
J Cardiothorac Surg. 2014 Sep 05;9:146
pubmed: 25190316
J Thorac Cardiovasc Surg. 1995 Apr;109(4):632-5
pubmed: 7715209
J Thorac Dis. 2019 Sep;11(9):4039-4048
pubmed: 31656680
Eur J Cardiothorac Surg. 2003 Feb;23(2):233-7
pubmed: 12559348
Eur J Cardiothorac Surg. 2008 Nov;34(5):1062-7
pubmed: 18760934
Eur J Cardiothorac Surg. 2003 Aug;24(2):187-9; discussion 190-1
pubmed: 12895605
N Engl J Med. 2016 Aug 11;375(6):511-22
pubmed: 27509100
Ann Thorac Surg. 2000 May;69(5):1537-41
pubmed: 10881838
Ann Thorac Surg. 1996 Sep;62(3):853-9
pubmed: 8784019

Auteurs

Mitsuteru Yoshida (M)

Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, Japan.

Masao Yuasa (M)

Department of Radiology, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, Japan.

Kazuya Kondo (K)

Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, Japan.

Mitsuhiro Tsuboi (M)

Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, Japan.

Naoya Kawakita (N)

Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, Japan.

Akira Tangoku (A)

Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH